vs
CVRx, Inc.（CVRX）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
CVRx, Inc.的季度营收约是RIVERVIEW BANCORP INC的1.1倍（$16.0M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -74.5%，领先84.3%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs 4.4%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-9.8M），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs 22.0%）
CVRx, Inc.是一家处于商业化阶段的医疗科技企业，专注于慢性心血管疾病神经调节疗法的研发与商业化，旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压，核心市场覆盖北美、欧洲，服务对常规药物治疗应答不佳的患者。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
CVRX vs RVSB — 直观对比
营收规模更大
CVRX
是对方的1.1倍
$14.0M
营收增速更快
RVSB
高出5.9%
4.4%
净利率更高
RVSB
高出84.3%
-74.5%
自由现金流更多
RVSB
多$9.1M
$-9.8M
两年增速更快
RVSB
近两年复合增速
22.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $16.0M | $14.0M |
| 净利润 | $-11.9M | $1.4M |
| 毛利率 | 86.3% | — |
| 营业利润率 | -69.8% | 12.4% |
| 净利率 | -74.5% | 9.8% |
| 营收同比 | 4.4% | 10.4% |
| 净利润同比 | -12.0% | 11.8% |
| 每股收益（稀释后） | $-0.45 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVRXRVSB
| Q4 25 | $16.0M | $14.0M | ||
| Q3 25 | $14.7M | $13.6M | ||
| Q2 25 | $13.6M | $13.3M | ||
| Q1 25 | $12.3M | $12.9M | ||
| Q4 24 | $15.3M | $12.7M | ||
| Q3 24 | $13.4M | $12.8M | ||
| Q2 24 | $11.8M | $12.2M | ||
| Q1 24 | $10.8M | $9.0M |
净利润CVRXRVSB
| Q4 25 | $-11.9M | $1.4M | ||
| Q3 25 | $-12.9M | $1.1M | ||
| Q2 25 | $-14.7M | $1.2M | ||
| Q1 25 | $-13.8M | $1.1M | ||
| Q4 24 | $-10.7M | $1.2M | ||
| Q3 24 | $-13.1M | $1.6M | ||
| Q2 24 | $-14.0M | $966.0K | ||
| Q1 24 | $-22.2M | $-3.0M |
毛利率CVRXRVSB
| Q4 25 | 86.3% | — | ||
| Q3 25 | 86.8% | — | ||
| Q2 25 | 84.3% | — | ||
| Q1 25 | 83.5% | — | ||
| Q4 24 | 83.2% | — | ||
| Q3 24 | 83.2% | — | ||
| Q2 24 | 83.9% | — | ||
| Q1 24 | 85.0% | — |
营业利润率CVRXRVSB
| Q4 25 | -69.8% | 12.4% | ||
| Q3 25 | -83.5% | 10.2% | ||
| Q2 25 | -105.8% | 11.7% | ||
| Q1 25 | -108.8% | 11.3% | ||
| Q4 24 | -67.0% | 12.4% | ||
| Q3 24 | -97.3% | 15.5% | ||
| Q2 24 | -118.3% | 10.0% | ||
| Q1 24 | -206.4% | -47.5% |
净利率CVRXRVSB
| Q4 25 | -74.5% | 9.8% | ||
| Q3 25 | -87.6% | 8.1% | ||
| Q2 25 | -108.4% | 9.2% | ||
| Q1 25 | -111.5% | 8.9% | ||
| Q4 24 | -69.4% | 9.7% | ||
| Q3 24 | -98.0% | 12.2% | ||
| Q2 24 | -118.8% | 7.9% | ||
| Q1 24 | -206.0% | -34.7% |
每股收益（稀释后）CVRXRVSB
| Q4 25 | $-0.45 | $0.07 | ||
| Q3 25 | $-0.49 | $0.05 | ||
| Q2 25 | $-0.57 | $0.06 | ||
| Q1 25 | $-0.53 | $0.05 | ||
| Q4 24 | $-0.39 | $0.06 | ||
| Q3 24 | $-0.57 | $0.07 | ||
| Q2 24 | $-0.65 | $0.05 | ||
| Q1 24 | $-1.04 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.3M | $164.2M |
| 总资产 | $104.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVRXRVSB
| Q4 25 | $75.7M | $28.6M | ||
| Q3 25 | $85.1M | $32.8M | ||
| Q2 25 | $95.0M | $34.2M | ||
| Q1 25 | $102.7M | $29.4M | ||
| Q4 24 | $105.9M | $25.3M | ||
| Q3 24 | $100.2M | $31.0M | ||
| Q2 24 | $70.4M | $27.8M | ||
| Q1 24 | $80.1M | $23.6M |
股东权益CVRXRVSB
| Q4 25 | $39.3M | $164.2M | ||
| Q3 25 | $48.1M | $163.5M | ||
| Q2 25 | $57.9M | $162.0M | ||
| Q1 25 | $71.1M | $160.0M | ||
| Q4 24 | $71.1M | $158.3M | ||
| Q3 24 | $65.2M | $160.8M | ||
| Q2 24 | $55.2M | $155.9M | ||
| Q1 24 | $66.3M | $155.6M |
总资产CVRXRVSB
| Q4 25 | $104.8M | $1.5B | ||
| Q3 25 | $111.3M | $1.5B | ||
| Q2 25 | $119.6M | $1.5B | ||
| Q1 25 | $129.6M | $1.5B | ||
| Q4 24 | $133.4M | $1.5B | ||
| Q3 24 | $127.7M | $1.5B | ||
| Q2 24 | $96.0M | $1.5B | ||
| Q1 24 | $106.2M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | $-736.0K |
| 自由现金流率自由现金流/营收 | -61.3% | -5.2% |
| 资本支出强度资本支出/营收 | 0.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-40.8M | $20.4M |
8季度趋势，按日历期对齐
经营现金流CVRXRVSB
| Q4 25 | $-9.8M | $-506.0K | ||
| Q3 25 | $-9.7M | $16.8M | ||
| Q2 25 | $-7.9M | $-697.0K | ||
| Q1 25 | $-12.8M | $8.3M | ||
| Q4 24 | $-8.0M | $2.2M | ||
| Q3 24 | $-10.4M | $764.0K | ||
| Q2 24 | $-9.8M | $5.4M | ||
| Q1 24 | $-10.9M | $12.8M |
自由现金流CVRXRVSB
| Q4 25 | $-9.8M | $-736.0K | ||
| Q3 25 | $-10.0M | $16.4M | ||
| Q2 25 | $-8.0M | $-773.0K | ||
| Q1 25 | $-12.9M | $5.6M | ||
| Q4 24 | $-8.1M | $1.9M | ||
| Q3 24 | $-10.4M | $-1.4M | ||
| Q2 24 | $-10.2M | $5.3M | ||
| Q1 24 | $-11.8M | $7.1M |
自由现金流率CVRXRVSB
| Q4 25 | -61.3% | -5.2% | ||
| Q3 25 | -68.1% | 120.1% | ||
| Q2 25 | -59.2% | -5.8% | ||
| Q1 25 | -104.3% | 43.1% | ||
| Q4 24 | -52.5% | 15.0% | ||
| Q3 24 | -78.1% | -11.3% | ||
| Q2 24 | -86.3% | 43.7% | ||
| Q1 24 | -109.7% | 79.0% |
资本支出强度CVRXRVSB
| Q4 25 | 0.4% | 1.6% | ||
| Q3 25 | 2.0% | 2.9% | ||
| Q2 25 | 0.8% | 0.6% | ||
| Q1 25 | 0.9% | 21.0% | ||
| Q4 24 | 0.3% | 2.4% | ||
| Q3 24 | 0.3% | 17.3% | ||
| Q2 24 | 3.0% | 0.9% | ||
| Q1 24 | 8.5% | 62.0% |
现金转化率CVRXRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
RVSB
暂无分部数据
